Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro.
Conclusions: These results complement our previous reports demonstrating that EPA and DHA prevent ECM accumulation and inflammation that typify the fibrotic process, providing new insights into the cellular and molecular mechanisms underlying their beneficial effects. We confirm that n-3 PUFAs could effectively counteract kidney fibrosis development providing a rationale for their use in clinical settings.
PMID: 22878980 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)